Search Press releases Keywords From To 10 Dec 2021 UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis Read More 3 Dec 2021 Disposals of own shares Read More 3 Dec 2021 UCB to present new data at the American Epilepsy Society 75th Annual Meeting 2021 reinforcing long-standing commitment to advancing epilepsy treatment and care Read More 2 Dec 2021 UCB Announces Global Partnership to Bring Disease-Modifying Therapies to People Living with Parkinson’s Disease Read More 30 Nov 2021 UCB and Chiesi enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases Read More 26 Nov 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 40 Page 41 Page 42 Page 43 Current page 44 Page 45 Page 46 Page 47 Page 48 … Page 44 of 69 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
